Evaluation of an online Diabetes Needs Assessment Tool (DNAT) for health professionals: a randomised controlled trial.
BACKGROUND
Continuous medical education is traditionally reliant to a large extent on self-directed learning based on individuals' perceived learning priorities. Evidence suggests that this ability to self-assess is limited, and more so in the least competent. Therefore, it may be of benefit to utilise some form of external assessment for this purpose. Many diabetes educational programmes have been introduced, but few have been assessed for their benefit in a systematic manner. As diabetes is an increasingly prevalent disease, methods for the dissemination and understanding of clinical guidelines need to be explored for their effectiveness. This paper describes the study design of a randomised controlled trial to evaluate the effectiveness of using an interactive online Diabetes Needs Assessment Tool (DNAT), that builds a learning curriculum based on identified knowledge gaps, compared with conventional self-directed learning. The study assesses the effect of these interventions on health professionals' knowledge of diabetes management, evaluates the acceptability of this process of learning and self-reported changes in clinical practice as a result of this novel educational process.


METHODS
Following a baseline assessment, participants will be randomised to undergo a 4-month learning period where they will either be given access to the diabetes learning modules alone (control group) or a Diabetes Needs Assessment Tool (DNAT) plus the diabetes learning modules (intervention group). On completion of the DNAT, a personalized learning report will be created for each participant identifying needs alongside individualised recommendations of the most appropriate learning modules to meet those requirements. All participants will complete a Diabetes Knowledge Test before and immediately after the allocated learning and the primary outcome will be the state of knowledge at 4 months. Learners will also be surveyed immediately after the learning period to assess the acceptability of the learning formats and the perceived usefulness and usability of the materials. After a further month, all learners will receive a series of questions to evaluate self-reported changes in clinical practice as a result of this educational experience and asked to include specific examples of any changes in their diabetes care practice.


BACKGROUND
Current Controlled Trials ISRCTN67215088.
Schroter
Sara
S
BMJ Editorial Office, BMJ Group, BMA House, London, UK. sschroter@bmj.com
Jenkins
Dean
D
Playle
Rebecca
R
Walsh
Kieran
K
Probert
Courtenay
C
Kellner
Thomas
T
Arnhofer
Gerhard
G
Owens
David
D
D003194:Computer-Assisted Instruction / Q000379:methods*; D003920:Diabetes Mellitus / Q000628:therapy*; D004502:Education, Medical, Continuing / Q000379:methods*; D006801:Humans; D020407:Internet; D020380:Needs Assessment; D012107:Research Design